雍禾医疗（02279.HK）今日盘中表现亮眼，股价大涨7.37%，引发市场关注。截至上午10时19分，该股报1.020港元/股，成交量2500股，换手率0.00%，振幅5.26%。
雍禾医疗股价上涨的主要原因可能与公司2024年业绩显著改善有关。据报道，雍禾医疗在2024年实现营收18.05亿元，同比增长1.5%，EBITDA盈利1.41亿元，业绩较此前有明显改善。值得注意的是，公司毛利同比增长8.7%至10.84亿元，毛利率达到60.1%，表明公司盈利能力有所提升。
雍禾医疗自2022年起进入自我调整变革期，采取了一系列措施重塑商业模式。公司暂停了快速扩店战略，优化了9家低效院部，将植发医疗机构从51家缩减至42家，史云逊独立门店也从13家减至8家。公司董事长张玉表示，这些"内修"举措虽然短期内可能面临"阵痛"，但长远来看将增强公司的市场竞争力，为企业未来长远发展奠定基础。投资者似乎对公司的战略调整和业绩改善持积极态度，推动了股价的上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.